New collaboration brings faster, digital-first counterfeit detection to the front lines of pharmaceutical brand protection.

Helsinki, Finland – July 15, 2025 — TrueMed, a global leader in AI-based counterfeit detection, announced today a strategic collaboration with Alliance Pharmaceuticals Ltd, a U.S.-based pharmaceutical solutions provider, to proactively safeguard medicines and consumer healthcare products from a growing threat: increasingly sophisticated counterfeit products that often appear identical to the real thing.

Over the past five years, counterfeiters have dramatically improved the quality of fake packaging, making counterfeits extremely hard to detect with the naked eye. Alliance Pharmaceuticals Ltd, recognizing the urgent need for next-generation tools, has shifted from a reactive to a proactive market protection strategy leveraging TrueMed’s digital authentication technology to identify and act on threats instantly.

“You can’t fight 2025 counterfeits with 2010 tools,” said Jyrki Berg, CEO of TrueMed. “Our collaboration with Alliance Pharmaceuticals Ltd shows what modern brand protection looks like: fast, digital, and verifiable. Instead of waiting weeks to collect and analyze samples, Alliance now reacts in real-time—protecting patients and their brand with the speed and precision that only AI can deliver.”

The new approach allows Alliance Pharmaceuticals Ltd to go beyond traditional investigations by:

• Scanning product complaint images using TrueMed’s AI platform to detect minute inconsistencies invisible to the human eye
• Generating immediate, digital evidence reports without the need to physically ship suspicious packaging
• Monitoring markets continuously and acting on digital signals within hours, not days

As a result of these factors and Alliance’s comprehensive brand protection strategy including online monitoring, offline enforcement, and more, the prevalence of counterfeits across targeted product lines has been significantly reduced from 50% down to <5%, all while maintaining fully digitized data for compliance, reporting, and ongoing analysis.

“This partnership allows us to shift from defense to offense,” said Rhodri Smith, Head of Global Brand Protection at Alliance Pharma. “Instead of waiting for bad actors to erode trust in our products, we now go after them with precision. TrueMed’s technology gives us a new kind of visibility and the speed to act before patients are put at risk.”

This collaboration reinforces a shared commitment to protecting patients, ensuring product authenticity, and modernizing pharmaceutical brand defense in a digital-first world.

About TrueMed TrueMed is a leading provider of anti-counterfeiting technology solutions. The company’s AI-enabled platform uses cutting-edge technology to analyze and identify potential counterfeit products, allowing companies to quickly and efficiently protect their brands and their customers.

For more information, please visit truemedinc.com. Contact: Tuomas Kannas, TrueMed, tuomas.kannas@truemedinc.com

About Alliance Pharma Alliance Pharmaceuticals Ltd is a growing consumer healthcare company. Our purpose is to empower people to make a positive difference to their health and wellbeing by making our trusted and proven brands available around the world.

A Global Snapshot of a Growing Crisis

Counterfeit and substandard medicines continue to pose a serious global health risk. In June 2025 alone, authorities across multiple continents uncovered massive fake drug operations, issued urgent public warnings, and exposed vulnerabilities in health systems from Africa to Asia and Europe. Here’s a round-up of the most pressing headlines.

Africa: Cancer Drug Crisis and Widespread Fakes

A report from DW revealed that nearly 20% of cancer medications in four African countries were defective or falsified. In some cases, patients received injections of nothing more than water.

In Kenya, the Eastleigh Voice cited research showing that up to 30% of medicines across Africa are counterfeit, a figure highlighting the scale of the crisis.

Nigeria remains one of the hardest-hit countries. Punch Nigeria published a harrowing report on the real-life toll of fake drugs, describing how patients are dying in plain sight. Meanwhile, People Daily reported that even hospitals are unwittingly giving counterfeit medications to patients.

India: Multiple Busts and Systemic Gaps

Several large-scale operations in India uncovered widespread counterfeiting:

• In Uttarakhand, Garhwal Post reported a major fake medicine racket being dismantled by the Special Task Force.

• Nagpur Today covered a similar bust in Maharashtra, targeting a distributor network.

• In Delhi, The New Indian Express and The420.in reported that counterfeit anti-cancer drugs were being sold in reused original vials.

The Munsif Daily and South First highlighted counterfeit heart medications being sold under the name of Sun Pharma, while WB Pay reported that 188 drugs failed quality tests, including life-saving injections.

On a regulatory front, PharmaBiz pointed out that thousands of pharma companies in India are operating without proper licenses.

Vietnamese outlet SGGP offered a deep dive into counterfeit and substandard drugs being sold across all price ranges, compounded by poor government oversight and difficulties in recalling dangerous products.

Middle East and Europe: Political Ties and Mass Seizures

In Lebanon, Agenzia Nova reported a major scandal involving the brother of a former finance minister linked to a counterfeit drug operation.

In the UK, the MHRA seized 77 million doses of illegal medicines and removed hundreds of illegal online listings as part of a major operation to crack down on pharmaceutical crime.

Interpol’s largest-ever global operation resulted in 769 arrests and $65 million in fake drugs seized worldwide.

Australia and the U.S.: Public Alerts and Opioid Concerns

In Canberra, Australia’s health department issued a public health alert after dangerous substances were found in counterfeit Xanax tablets.

In the U.S., a Tennessean report covered risks associated with GLP-1 weight-loss drugs like semaglutide, particularly those sourced from unverified compounding pharmacies.

At a continental level, the Belgian news agency warned of a surge in synthetic opioids and reported over 7,500 drug-related deaths in the EU in 2023.

Global: A Rising Threat

A Prime Media editorial summed it up best: the fake medicine threat is global, growing, and increasingly sophisticated. There’s no single solution—but global awareness, rapid detection, and tighter enforcement are urgently needed.

Final Thoughts

From anti-cancer treatments to anxiety medications and cholesterol pills, no therapeutic class seems immune from counterfeiting. June’s wave of discoveries reinforces the need for stronger detection tools, cross-border collaboration, and public education to stay ahead of increasingly advanced counterfeit operations.

Stay informed, stay skeptical—and always verify your sources.

Global Counterfeit Drug News: May 2025 Roundup

May 2025 revealed a disturbing uptick in counterfeit drug incidents around the world. From factory raids to synthetic opioid warnings and fake cancer treatments, authorities across continents are grappling with increasingly sophisticated threats to public health. Here’s a roundup of major stories from the past month:

Africa

• Nigeria’s NAFDAC Fights Back: Despite pressure, Nigeria’s drug authority reaffirmed its zero-tolerance stance on counterfeit medicines. Read more

• Fake Drug Factory Busted in Delta State: NAFDAC shut down an illegal operation producing fake medications in southern Nigeria. Read more

• Media Exposes Broader Threat: Coverage highlights the increasing health risks posed by counterfeit drugs flooding Nigerian markets. Read more

Asia

• Vietnam’s Deepening Crisis: Pharmacies were caught selling fake drugs with dangerously low potency in Hanoi. Read more
  Broader analysis shows fake medicines now threaten both food safety and public health nationwide. Read more
  Authorities are sounding the alarm. Read more

• Pakistan’s Azad Kashmir in Trouble: A scathing editorial accuses the local government of failing to tackle counterfeit medicine distribution. Read more

• India Sees Major Arrest: Delhi police apprehended a key suspect in a fake cancer medicine ring. Read more
  Jharkhand introduced QR-code mandates to protect against fakes. Read more

• Crackdowns and Commentary: Other Indian states ramped up enforcement. Read more
  Editorial coverage emphasized the need for urgent regulatory reforms. Read more
  Another editorial warned of worsening public health outcomes without stronger oversight.

United States

• GLP-1 Drug Warning: Counterfeit weight-loss medications prompted warnings from state attorneys general. Read more

• Novo Nordisk Takes Legal Action: The pharmaceutical giant initiated lawsuits to protect its semaglutide brand from counterfeiting. Read more

• Spotify Under Fire: Podcasts promoting illegal prescription drug sales led to takedown efforts. Read more

Australia

• Deadly Synthetic Opioid Found: Fake pharmaceutical drugs containing a dangerous synthetic opioid were discovered. Read more

Other Updates

• Paracetamol Warning in the Philippines: The FDA warned the public about counterfeit paracetamol in circulation. Read more

• Global Coordinated Efforts Begin: Some nations are launching joint crackdowns. Read more

Conclusion
From Asia to Africa and North America to Oceania, May was a sobering reminder of how global and urgent the counterfeit drug problem has become. As authorities respond with crackdowns and companies ramp up authentication efforts, the role of real-time detection technologies and global cooperation will only grow more critical.

Spotting a fake is just the beginning. What happens next is what truly matters.

With TrueMed, detection instantly triggers a chain of smart, secure, and strategic actions. From real-time alerts and secure data capture to automated response plans and evolving intelligence, every scan builds your ability to respond faster — and smarter — the next time.

Here’s what unfolds the moment a counterfeit enters the system.

1. Instant Alert, Verified in Seconds

As soon as a counterfeit is flagged through the TrueMed platform, an alert is triggered. The system cross-checks the suspected inspection against your verified product database — looking for packaging printing to suspect issues, mismatched codes, invalid packaging details, suspicious geolocation, and usage anomalies.

If it’s fake, you know within seconds.
No long investigations. No guesswork. Just a confirmed counterfeit.  If needed, results can be quickly confirmed by a human without sending the product to a forensic lab. This allows for a rapid field response based on where the suspect product is found and any upcoming activity in that area.

2. Secure Data Capture in Real Time

Each inspection adds more than a result — it adds context:

• Where was the scan performed?

• What does the suspected product look like? Is it authentic? What manufacturing errors are present? Can these patterns be linked to previous cases to indicate systematic counterfeiting across different geolocations?

• What product and batch was it mimicking & exp dates (or serial number if available)?

• How often has this code appeared elsewhere?

• This metadata is instantly logged, encrypted, and routed into your incident management dashboard. You don’t just see that there’s a problem — you see where it’s happening and how it’s evolving.

3. Triggered Response Plans

TrueMed’s platform can automatically notify your internal teams, law enforcementg, or regulatory contacts depending on how you’ve configured alerts. That means:

• Your forensic lab people can go and further analyze / confirm the target and instantly print a full PDF report of the case.

• Your supply chain team sees early indicators of diversion.

• Your legal team gets notified to investigate IP infringement.

• Your field force gets real-time instructions to investigate.

Think of it as a digital early warning system—customized to your operations.

4. Intelligence That Grows Over Time

Every detected fake becomes a new data point in a continuously growing counterfeit intelligence network. The more you scan, the smarter your system becomes.

• New scan patterns emerge

• Packaging fraud trends are tracked

• High-risk regions are flagged automatically

This feedback loop gives you a strategic edge — and it’s something visual-only solutions can’t deliver.

5. Actionable Reports That Drive Change

Weekly and monthly reports are automatically generated to highlight trends and anomalies. This helps you:

• Adjust packaging strategies

• Pinpoint vulnerable supply chain links

• Collaborate more effectively with regulatory agencies and enforcement partners

From field scan to global strategy — TrueMed connects the dots.

The Bottom Line

TrueMed is more than just a scan-and-detect tool. It’s a full-circle defense system that helps you respond faster, smarter, and with real data in hand.

Because stopping counterfeits isn’t about catching fakes one at a time — it’s about learning from every scan and building a defense that scales with the threat.

Legacy security features don’t stop modern counterfeiters. Here’s what future-ready pharma looks like.

Counterfeiting is no longer a small-scale problem or a distant-market threat. It’s a sophisticated, global business that adapts as fast as your products launch. And while your packaging might still include tamper seals, color-shifting inks, or hidden marks — those tools were cutting edge in 2010.

The question is: Have your defenses evolved fast enough to meet the counterfeiters of today — and tomorrow?

2010: The Era of Visual Security

Let’s rewind. A decade ago, packaging innovation focused on what consumers and inspectors could see:

• Holograms
• UV inks
• Color-shifting seals
• Hidden watermarks
• Serialization for prescription medicines

These were useful deterrents — until they weren’t. Today, counterfeiters can replicate most of these features with commercial-grade printers and online tutorials.

According to the OECD and EUIPO, even high-end holograms are easily forged and now provide “limited deterrence.”

Still Using Yesterday’s Tools?

If your anti-counterfeit checklist still includes:

• Holograms
• Color-shifting inks or markings
• Static or even dynamic QR codes

…you’re working with tools designed to fight a version of counterfeiting that no longer exists.

2030: Data-Driven Authentication at Scale

The future of product protection isn’t about what’s printed — it’s about what’s proven through real-time data, context-aware validation, and global traceability.

Dynamic IDs Instead of Static Codes

QR codes are static. Future-ready solutions rely on encrypted, rotating identifiers tied to manufacturing and distribution data that can’t be guessed or copied. Serialization has started to fill this gap with prescription drugs. A great step, but not yet enough.

Smartphone Verification—For Everyone

Empowering patients, pharmacists, and field teams to instantly verify product authenticity via a scan — with no specialized hardware.

Global Threat Intelligence

Each scan contributes to a broader database of counterfeit activity. It’s not just detection — it’s networked defense. A scan in Brazil can trigger a flag in Belgium. Counterfeiters cross borders, products, and brands. Your response should be just as coordinated and far-reaching.

What 2030 Looks Like Today — With TrueMed

In today’s world, meeting compliance standards is no longer enough. Brands need smarter, faster ways to defend against counterfeiting without slowing down operations or adding complexity.

At TrueMed, we believe your product and packaging should be able to protect themselves. No redesigns. No added materials. No factory modifications. Just a seamless layer of intelligence that turns every unit into its own line of defense.

Our platform connects global data streams with AI-powered authentication, giving you real-time clarity and control. The result is instant detection, rapid response, and a system that evolves just as fast as the threats.

This isn’t a patch. It’s a future-proof foundation.

The next era of brand protection is here. Digital. Scalable. Always on. Let’s bring your anti-counterfeit strategy into the future starting today.

April 2025 Counterfeit Medicine News Roundup: Global Seizures, Warnings, and Investigations

April saw a global surge in enforcement activity, awareness campaigns, and alarming discoveries tied to counterfeit medicines. Here’s a comprehensive roundup of the most important news from around the world:

🚨 Counterfeit Seizures and Investigations

• FDA Cracks Down on Counterfeit Ozempic in the U.S.
  The FDA seized hundreds of units of fake Ozempic amid growing concerns about counterfeit semaglutide in the supply chain.
  Read more
  FDA and Novo Nordisk investigating counterfeit semaglutide

• Canada: RCMP Warns of Lethal Counterfeit Pills in Circulation
  Canadian authorities raised the alarm about fake pills containing dangerously high levels of toxic substances.
  Read more

• India: NAFDAC Blocks Influx from China and India
  Nigerian authorities intensified border enforcement to block substandard and counterfeit products, with a focus on shipments from China and India.
  Read more

• Vietnam: Counterfeit Ring Rakes in Nearly $8 Million
  A sophisticated interprovincial counterfeit drug network in Vietnam was dismantled, exposing a massive illicit operation.
  Read more

• Cameroon: Massive Fake Drug Destruction Operation
  Authorities destroyed a large haul of counterfeit medicines as part of a sweeping enforcement action.
  Read more

🏥  Supply Chain Concerns

• Delhi: Fake Medicines in Hospitals Spark Political Outrage
  Delhi’s Congress chief alleged that counterfeit drugs are being supplied in government hospitals.
  Read more

• Calls for Recall: Sun Pharma’s Levipil Under Scrutiny
  Pressure mounts on Sun Pharma to voluntarily recall Levipil-500 amid questions about its authenticity.
  Read more

• Malaria Drugs in Nigeria Under Investigation
  Experts raised fresh concerns about fake malaria drugs circulating in Nigerian pharmacies.
  Read more

🌐 Research & Public Awareness

• Mexico’s Fentanyl-Based Counterfeit Crisis in Pharmacies
  A scholarly article outlined the deadly threat of fentanyl-laced counterfeit medications sold openly in Mexican pharmacies.
  Read the publication

• Physicians in Egypt Warn of Rising Medical Forgery
  A study revealed that many Egyptian physicians are highly aware—and increasingly concerned—about counterfeit medicines in clinical practice.
  Full study PDF

📦 Other Notable Incidents

• India: Arrests Made in Fake Drug Shipment Case
  Authorities disrupted a scheme trafficking counterfeit drugs worth crores.
  Read more
  Related story
  Another bust

• UK: Dangerous Counterfeit Pills Enter the Market
  Counterfeit medications containing unsafe ingredients made their way into pharmacies and online sellers.
  Read more

• FDA Action on Illegal Online Pharmacy
  The FDA took action against an unauthorized website selling counterfeit drugs.
  Read more

• Fake Drug Syndicates Still Thriving Despite Enforcement
  An in-depth report discusses the persistence of sophisticated counterfeit drug networks.
  Read more

Takeaway
April’s developments paint a stark picture: counterfeit drugs are not only a global issue, but one infiltrating legitimate supply chains. From fake semaglutide injections to hospital-supplied counterfeits, the stakes have never been higher.

Want to stay informed about future counterfeit alerts and enforcement updates? Bookmark this blog and follow us for monthly roundups.

Don’t wait for an emergency to realize your brand is under attack.

Pharmaceutical counterfeiting is no longer just a problem in emerging markets or for high-profile lifestyle drugs — it’s a global, cross-category threat. But while counterfeiters are getting smarter, they often leave behind subtle clues that your brand is being targeted. The key is knowing what to look for before the damage is done.

Here are five red flags that may indicate counterfeit versions of your product are circulating in the market:

1. Unusual Spikes in Product Returns

If you’re seeing a sudden increase in returns or complaints — especially from regions where you have limited distribution — take note. Counterfeit products often don’t perform as expected, leading customers or pharmacies to flag issues. Watch for vague complaints like “ineffective treatment” or “strange smell” that don’t align with your product’s known safety profile.

2. Inconsistent Batch Numbers or Packaging Anomalies

Your packaging team follows strict protocols. So when you start spotting slight font differences, missing serial codes, or batch numbers that were never produced — that’s a red flag. Counterfeiters frequently try to mimic batch codes but get small details wrong. These inconsistencies can signal fake products trying to piggyback off your supply chain legitimacy.

3. Distribution Patterns That Don’t Make Sense

Have you noticed products showing up in markets where you don’t have authorized partners? Or in quantities that don’t align with your shipments? Counterfeits often enter through gray markets and unregulated channels. Distributors might not even realize they’re carrying fake stock — but your brand will take the hit.

4. A Surge in Online or Social Media Mentions

Counterfeits are increasingly sold via social media, online marketplaces, or unauthorized websites. Occasionally they also break into the legal supply chain that is not favoring the manufacturers counterfeit defense. If you’re suddenly tagged in strange posts, or your product is being offered on platforms you don’t supply to — it’s time to investigate. Social listening tools can help, but scan-based verification adds a much-needed layer of real-world intelligence. 

5. Complaints from Healthcare Providers or Wholesalers

Your frontline allies — pharmacists, physicians, and distribution partners — are often the first to notice when something’s off. Whether it’s customer complaints, performance issues, or concerns about packaging, don’t ignore these early alerts. They may be the first sign that counterfeit versions of your product are being passed off as the real thing.

What You Can Do

Being aware of these red flags is the first step — but detecting counterfeits in real time is the game-changer. TrueMed’s platform uses instant, mobile-first scanning technology to identify fakes on the spot and feed verified data into a growing intelligence network. That means faster detection, faster action, and less brand damage.

Counterfeiters aren’t waiting. Neither should you.

Counterfeiting isn’t just a field problem—it’s a data problem.

At TrueMed, we understand that scanning for fake products is only the beginning. The real value lies in what happens after detection: capturing that data and turning it into long-term strategic advantage. That’s where a digital counterfeit database comes in.

Why Build a Counterfeit Database?

Today, counterfeit data is scattered. Reports come from different sources, in different formats, and often live in silos. This fragmentation slows down enforcement efforts and leaves businesses vulnerable.

Consolidation is the answer. By bringing all counterfeit intelligence into a single, searchable platform, companies can take faster, smarter action.

TrueMed’s platform makes this easy. Every scan you perform in the field feeds directly into your secure digital database. It’s automatic, seamless, and scalable.

From Detection to Strategy

Your database isn’t just a log of incidents—it’s a launchpad for action. With TrueMed, every data point becomes part of a larger story, helping you:

• Plan Investigations – Spot trends across regions and product lines, then focus your enforcement resources where they matter most.

• Improve Packaging – Use data to guide updates to packaging and anti-counterfeit features based on what’s actually being faked.

• Stay Ahead – Move from reactive to proactive. Predict and prevent counterfeiting before it becomes a bigger problem.

The More You Add, The Smarter It Gets

A digital counterfeit database compounds in value over time. Every scan adds insight. Every case builds intelligence. Over time, you develop a clear picture of what’s happening—where, how, and why.

And because TrueMed’s system is built for scale, it doesn’t matter if you’re tracking five incidents or five thousand. The database grows with you.

Consolidation + Case Management = Control

Rather than dealing with scattered PDFs, spreadsheets, or reports buried in inboxes, TrueMed gives you a centralized, always-updated hub. It’s not just a record—it’s a live intelligence system designed to help you make better decisions, faster.

Fighting counterfeits isn’t just about catching them—it’s about staying ahead of them. With TrueMed, you’re not just reacting. You’re building a smarter, more connected defense.

Ready to Turn Your Data Into Defense?

Start consolidating your counterfeit insights today. TrueMed makes it easy to go from scan to strategy—so you can protect your supply chain with confidence.

Let’s build the future of anti-counterfeiting together.  Contact Us Today!